CN110267683A - 固体制剂 - Google Patents

固体制剂 Download PDF

Info

Publication number
CN110267683A
CN110267683A CN201880009378.4A CN201880009378A CN110267683A CN 110267683 A CN110267683 A CN 110267683A CN 201880009378 A CN201880009378 A CN 201880009378A CN 110267683 A CN110267683 A CN 110267683A
Authority
CN
China
Prior art keywords
pharmaceutical preparation
solid pharmaceutical
tablet
gelating agent
uncoated tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880009378.4A
Other languages
English (en)
Chinese (zh)
Inventor
根岸辰成
和泉光人
山口和也
高垣欣也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Shinyaku Co Ltd
Original Assignee
Toyo Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Shinyaku Co Ltd filed Critical Toyo Shinyaku Co Ltd
Publication of CN110267683A publication Critical patent/CN110267683A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
CN201880009378.4A 2017-02-03 2018-02-02 固体制剂 Pending CN110267683A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2017018883 2017-02-03
JP2017-018883 2017-02-03
JP2017072905 2017-03-31
JP2017-072905 2017-03-31
PCT/JP2018/003640 WO2018143423A1 (ja) 2017-02-03 2018-02-02 固形製剤

Publications (1)

Publication Number Publication Date
CN110267683A true CN110267683A (zh) 2019-09-20

Family

ID=63040182

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880009378.4A Pending CN110267683A (zh) 2017-02-03 2018-02-02 固体制剂

Country Status (4)

Country Link
JP (5) JP7390695B2 (ja)
KR (1) KR102329377B1 (ja)
CN (1) CN110267683A (ja)
WO (1) WO2018143423A1 (ja)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016172A1 (en) * 1995-11-03 1997-05-09 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5648092A (en) * 1990-07-19 1997-07-15 Merck Patent Gesellschaft Mit Beschrankter Haftung Sucralfate chewable tablet
JP2002275054A (ja) * 2001-03-19 2002-09-25 Dainippon Pharmaceut Co Ltd 易服用性固形製剤
WO2017002803A1 (ja) * 2015-06-29 2017-01-05 株式会社ダイセル 固形製剤の外層用組成物及び該外層用組成物を含む易服用性固形製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080427A (en) 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
AU5904698A (en) 1997-12-29 1999-07-19 Procter & Gamble Company, The Tablet composition
US6572887B2 (en) 2000-05-01 2003-06-03 National Starch And Chemical Investment Holding Corporation Polysaccharide material for direct compression
MXPA06006677A (es) 2003-12-12 2006-08-31 Penwest Pharmaceuticals Co Formas de dosis de torasemida de liberacion sostenida.
JP2006117626A (ja) 2004-09-24 2006-05-11 Nisshin Pharma Inc コエンザイムｑ１０配合組成物の製造方法
US20070005933A1 (en) 2005-06-29 2007-01-04 Kopec Brian J Preventing multiple translation lookaside buffer accesses for a same page in memory
US20080305168A1 (en) 2006-02-10 2008-12-11 Kyo-Tae Moon In-Situ Melting and Gelling Tablet Composition For Oral Care
CL2008003230A1 (es) 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
JP5909851B2 (ja) 2010-02-24 2016-04-27 大正製薬株式会社 易嚥下性錠剤
AU2012334035A1 (en) 2011-11-10 2014-03-27 Dpx Holdings B.V. Lubricious coatings
JP6045237B2 (ja) 2012-07-27 2016-12-14 旭化成株式会社 錠剤型の増粘化剤
JP6045238B2 (ja) 2012-07-27 2016-12-14 旭化成株式会社 増粘多糖類を含む錠剤
KR102671429B1 (ko) * 2015-09-30 2024-05-30 주식회사 다이셀 복용 용이성 고형 제제용 입자 조성물 및 상기 입자 조성물을 포함하는 복용 용이성 고형 제제

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648092A (en) * 1990-07-19 1997-07-15 Merck Patent Gesellschaft Mit Beschrankter Haftung Sucralfate chewable tablet
WO1997016172A1 (en) * 1995-11-03 1997-05-09 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
JP2002275054A (ja) * 2001-03-19 2002-09-25 Dainippon Pharmaceut Co Ltd 易服用性固形製剤
WO2017002803A1 (ja) * 2015-06-29 2017-01-05 株式会社ダイセル 固形製剤の外層用組成物及び該外層用組成物を含む易服用性固形製剤

Also Published As

Publication number Publication date
JP7390750B2 (ja) 2023-12-04
JP2023184766A (ja) 2023-12-28
KR20190105631A (ko) 2019-09-17
JPWO2018143423A1 (ja) 2019-11-21
JP2018158917A (ja) 2018-10-11
JP7096593B2 (ja) 2022-07-06
WO2018143423A1 (ja) 2018-08-09
JP7390695B2 (ja) 2023-12-04
KR102329377B1 (ko) 2021-11-19
JP2023184779A (ja) 2023-12-28
JP2022120168A (ja) 2022-08-17

Similar Documents

Publication Publication Date Title
CN103721264B (zh) 一种用于助吞咽口服固体药物制剂的凝胶剂
WO2006082842A1 (ja) 溶解性が改善された硬カプセル
TWI733650B (zh) 含微小纖維狀之纖維素之崩解性粒子組成物
JPWO2013115171A1 (ja) 苦味マスク顆粒含有口腔内崩壊錠
JP5665372B2 (ja) 速崩壊性固形製剤
KR20200006594A (ko) 미소섬유상 셀룰로오스 및 유효 성분을 포함하는 붕해 정제용 조성물
KR20170086095A (ko) 분쇄 유당 또는 조립 유당을 포함하는 붕해성 입자 조성물
CN103826660A (zh) 含有羟烷基纤维素微粒的口腔内崩解片
AU2006263068B2 (en) Orally disintegrating powder comprising cilostazol and mannitol
CN110267683A (zh) 固体制剂
JP6104038B2 (ja) 結晶セルロースの複合組成物
TW202011943A (zh) 易服用性顆粒劑及其製造方法
JP5918584B2 (ja) 味マスキング方法
CN116270515B (zh) 一种提高贝前列素钠片产品质量的制备方法
JP5344938B2 (ja) 崩壊性固形製剤
CN107303395A (zh) 一种含有链霉蛋白酶的药物组合物及其制备方法
JP2016117731A (ja) 経口剤、経口剤の製造方法、経口固形剤のコーティング用組成物
TW201639598A (zh) 延遲崩解性粒子組成物
JP2023119660A (ja) 錠剤用基材、錠剤の崩壊促進用組成物、口腔用錠剤の食感および／または食味改良用組成物ならびに錠剤の製造方法
JP2014009211A (ja) イトラコナゾールを含有するゾル状の医薬組成物
JPH02221232A (ja) のみやすい医薬組成物
MX2008000114A (es) Polvo desintegrable oralmente que comprende cilostazol.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40009530

Country of ref document: HK